SG11201810015YA - Particle for the encapsidation of a genome engineering system - Google Patents

Particle for the encapsidation of a genome engineering system

Info

Publication number
SG11201810015YA
SG11201810015YA SG11201810015YA SG11201810015YA SG11201810015YA SG 11201810015Y A SG11201810015Y A SG 11201810015YA SG 11201810015Y A SG11201810015Y A SG 11201810015YA SG 11201810015Y A SG11201810015Y A SG 11201810015YA SG 11201810015Y A SG11201810015Y A SG 11201810015YA
Authority
SG
Singapore
Prior art keywords
encapsidation
particle
engineering system
genome engineering
viral rnas
Prior art date
Application number
SG11201810015YA
Inventor
Pascale Bouille
Régis Gayon
Lucille Lamouroux
Alexandra Iche
Original Assignee
Flash Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1654332A external-priority patent/FR3051196B1/en
Application filed by Flash Therapeutics filed Critical Flash Therapeutics
Publication of SG11201810015YA publication Critical patent/SG11201810015YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/85—Fusion polypeptide containing an RNA binding domain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
    • C12N2740/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/18011—Details ssRNA Bacteriophages positive-sense
    • C12N2795/18111—Leviviridae
    • C12N2795/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/24—Vectors characterised by the absence of particular element, e.g. selectable marker, viral origin of replication
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/50—Vectors for producing vectors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PARTICLE FOR THE ENCAPSIDATION OF A GENOME ENGINEERING SYSTEM The present invention relates to a retroviral particle comprising a protein derived from the Gag polyprotein, an envelope protein, optionally an integrase and at least two encapsidated non-viral RNAs, the encapsidated non-viral RNAs each comprising an RNA sequence of interest bound to an encapsidation sequence, each encapsidation sequence being recognized by a binding domain introduced into the protein derived from the Gag polyprotein and/or into the integrase, and at least one of said sequences of interest of the encapsidated non-viral RNAs comprises a part coding a nuclease. (No Suitable Figure)
SG11201810015YA 2016-05-13 2017-05-12 Particle for the encapsidation of a genome engineering system SG11201810015YA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR1654332A FR3051196B1 (en) 2016-05-13 2016-05-13 PARTICLE FOR ENCAPSIDATION OF A GENOME ENGINEERING SYSTEM
FR1660309 2016-10-24
FR1752818 2017-03-31
PCT/FR2017/051164 WO2017194902A2 (en) 2016-05-13 2017-05-12 Particle for the encapsidation of a genome engineering system

Publications (1)

Publication Number Publication Date
SG11201810015YA true SG11201810015YA (en) 2018-12-28

Family

ID=59070995

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201810015YA SG11201810015YA (en) 2016-05-13 2017-05-12 Particle for the encapsidation of a genome engineering system

Country Status (11)

Country Link
US (1) US10870865B2 (en)
EP (1) EP3455239B1 (en)
JP (1) JP6982001B2 (en)
AU (1) AU2017263137B2 (en)
CA (1) CA3024376A1 (en)
DK (1) DK3455239T3 (en)
ES (1) ES2886919T3 (en)
IL (1) IL262941B (en)
PT (1) PT3455239T (en)
SG (1) SG11201810015YA (en)
WO (1) WO2017194902A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016185125A1 (en) * 2015-05-15 2016-11-24 Vectalys Retroviral particle comprising at least two encapsidated non-viral rnas
EP3788155A1 (en) * 2018-05-01 2021-03-10 Wake Forest University Health Sciences Lentiviral-based vectors and related systems and methods for eukaryotic gene editing
CN108504689B (en) * 2018-05-29 2021-01-29 上海本导基因技术有限公司 Lentiviral vectors and methods of delivering exogenous RNA thereof
CA3196996A1 (en) * 2020-11-19 2022-05-27 Baisong Lu Vectors, systems and methods for eukaryotic gene editing

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0526210D0 (en) 2005-12-22 2006-02-01 Oxford Biomedica Ltd Vectors
US10273462B2 (en) 2011-07-27 2019-04-30 Vectalys Sas Virus-based vector compositions useful for transducing eukaryotic cells
WO2016049258A2 (en) * 2014-09-25 2016-03-31 The Broad Institute Inc. Functional screening with optimized functional crispr-cas systems

Also Published As

Publication number Publication date
EP3455239A2 (en) 2019-03-20
US10870865B2 (en) 2020-12-22
WO2017194902A2 (en) 2017-11-16
WO2017194902A3 (en) 2018-01-18
JP2019514414A (en) 2019-06-06
IL262941A (en) 2018-12-31
EP3455239B1 (en) 2021-04-07
PT3455239T (en) 2021-07-13
CA3024376A1 (en) 2017-11-16
AU2017263137B2 (en) 2021-05-27
CN109415415A (en) 2019-03-01
ES2886919T3 (en) 2021-12-21
DK3455239T3 (en) 2021-07-05
JP6982001B2 (en) 2021-12-17
US20200071720A1 (en) 2020-03-05
IL262941B (en) 2022-05-01
AU2017263137A1 (en) 2019-01-03

Similar Documents

Publication Publication Date Title
MX2022006652A (en) Modified capsid proteins for enhanced delivery of parvovirus vectors.
WO2018136396A3 (en) Crisprs
SG11201810015YA (en) Particle for the encapsidation of a genome engineering system
MX2019006467A (en) Compositions and methods for enhancing gene expression.
CY1124453T1 (en) POLYPEPTIDES CONTAINING DE NOVO BINDING REGIONS AND USES THEREOF
CY1121159T1 (en) NON-INTEGRATED LINTER BODIES
PH12019501130A1 (en) Viral delivery of neoantigens
CY1124518T1 (en) TRIMER STABILIZING HIV ENVELOPE PROTEIN MUTATIONS
MX2019002946A (en) Anti-pd-1(cd279) antibodies.
MX2017010857A (en) Methods for targeted nucleic acid sequence coverage.
MX2018005392A (en) Engineered nucleic-acid targeting nucleic acids.
WO2015191693A3 (en) Method for gene editing
EP4349404A3 (en) Respiratory virus vaccines
AU2016262093A8 (en) Enhancing endonuclease based gene editing in primary cells
AU2015286820A8 (en) Stabilization of poly(A) sequence encoding DNA sequences
WO2018191502A3 (en) Anti-cd137 antibodies and methods of use thereof
EA201201025A1 (en) NUCLEIC ACID MOLECULES OF INFLUENZA AND VACCINES PRODUCED FROM THEM
WO2017214327A3 (en) Non-integrating viral delivery system and methods related thereto
WO2009124312A3 (en) Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
BR112018010635A2 (en) stable cell lines for retroviral production
EA201992232A1 (en) COMPOSITIONS AND METHODS FOR IMMUNOUNCOLOGY
MX2017008096A (en) Pestivirus.
WO2012018907A3 (en) Polypeptides for treating and/or limiting influenza infection
MX2017005524A (en) Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development.
WO2018017747A3 (en) Oncolytic viruses targeting stat3